Since ANGPT-2 and VEGF-A are crucial regulators of vascular remodeling, co-targeting VEGF-A and ANGPT-2 in combination with chemotherapy in chemoresistant CRC xenograft models can be of paramount importance in future studies40. The gene discussed is ANGPT2; the disease is colorectal carcinoma.